Objectives
Phosphodiesterase 5 inhibitors (PDE5i) are considered among the first-line treatment options for erectile dysfunction (ED). Their impact in terms of long-term psychological well-being has been scantly analysed. This retrospective cross-sectional study aimed to investigate PDE5i...